1.Impact of Extended Lymph Node Dissection on Survival Outcomes in Patients With Bladder Cancer and Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study
Jiwoong YU ; Wook NAM ; Kyung Hwan KIM ; Yun-Sok HA ; Geehyun SONG ; Ho Kyung SEO ; Jong Kil NAM ; Tae Il NOH ; Seok Ho KANG ; Seung-Hwan JEONG ; Ja Hyeon KU ; Jong Jin OH ; Ji Eun HEO ; Won Sik HAM ; Joongwon CHOI ; Bumjin LIM ; Bumsik HONG ; Wan SONG ; Minyong KANG ; Hwang Gyun JEON ; Seong Il SEO ; Seong Soo JEON ; Hyun Hwan SUNG ; Byong Chang JEONG ;
Journal of Urologic Oncology 2025;23(1):79-87
Purpose:
To evaluate whether extended pelvic lymph node dissection (PLND) improves survival outcomes compared with standard PLND in patients with bladder cancer (BCa) undergoing radical cystectomy (RC), and to assess its potential benefits in patients with prior or concurrent radical nephroureterectomy (p/cRNU).
Materials and Methods:
A multicenter analysis included 2202 patients with BCa undergoing RC with standard or extended PLND at 11 tertiary centers from 2003 to 2023. Following propensity score matching, 659 pairs (n=1,318), including 128 patients with p/cRNU, were analyzed. Recurrence-free survival (RFS) was the primary outcome, while overall survival (OS), cancer-specific survival (CSS), and readmission rates were secondary outcomes. Survival analyses performed using Kaplan-Meier methods and clustered Cox models.
Results:
Extended PLND yielded significantly more lymph nodes than standard PLND (median: 27.0 vs. 17.0, p<0.001) but did not improve RFS, CSS, or OS in the overall cohort (all p>0.05). Extended PLND increased readmission rates (28.4% vs. 20.2%, p=0.001) and readmission risk (odds ratio, 1.57; 95% confidence interval [CI], 1.15–2.16, p=0.005). However, subgroup analysis revealed extended PLND significantly improved RFS in patients with p/cRNU (hazard ratio, 0.54; 95% CI, 0.38–0.77; p<0.001).
Conclusion
Extended PLND does not provide survival benefits for overall patient population and increases readmission risk but significantly improves RFS in patients with p/cRNU. Tailoring PLND extent based on upper tract disease status is recommended.
2.Long-term effect of bariatric surgery versus conventional therapy in obese Korean patients: a multicenter retrospective cohort study
Ji Yeon PARK ; Yoonseok HEO ; Yong Jin KIM ; Joong Min PARK ; Seong Min KIM ; Do Joong PARK ; Sang Kuon LEE ; Sang Moon HAN ; Kyung Won SHIM ; Yeon Ji LEE ; Ja Youn LEE ; Jin Won KWON
Annals of Surgical Treatment and Research 2019;96(6):283-289
PURPOSE: Long-term results following bariatric surgery compared to conventional treatments has never been reported in morbidly obese Korean patients. This study aimed to evaluate the long-term efficacy of bariatric surgery in morbidly obese Korean patients compared to conventional medical treatments. METHODS: In this multicenter retrospective cohort study, we reviewed 137 obese subjects between January 2008 and February 2011 with a body mass index (BMI) > 30 kg/m2 who had more than 5 years of follow-up clinical data after bariatric surgery (surgery group, n = 49) or conventional treatment (conventional treatment group, n = 88). Anthropometric data and the status of comorbidities were compared between the 2 groups. RESULTS: The median follow-up period was 72.1 months (range 19.3–109.7 months). At the last follow-up, the surgery group showed a greater amount of total weight loss than the conventional treatment group (24.9% vs. 2.8%, P < 0.001). The prevalence of diabetes and hypertension significantly decreased in the surgery group, while the conventional treatment group showed a marked increase in these comorbidities. In the surgery group, Roux-en-Y gastric bypass and sleeve gastrectomy achieved comparable long-term weight loss (26.5% vs. 22.4%, respectively; P = 0.087). CONCLUSION: In the long-term, bariatric surgery achieved and maintained significantly greater weight reduction, as well as a decrease in obesity-related comorbidities, than did conventional medical therapy in morbidly obese Korean patients.
Bariatric Surgery
;
Body Mass Index
;
Cohort Studies
;
Comorbidity
;
Follow-Up Studies
;
Gastrectomy
;
Gastric Bypass
;
Humans
;
Hypertension
;
Obesity, Morbid
;
Prevalence
;
Retrospective Studies
;
Weight Loss
3.Roux-en-Y Gastric Bypass vs. Sleeve Gastrectomy vs. Gastric Banding: The First Multicenter Retrospective Comparative Cohort Study in Obese Korean Patients.
Sang Kuon LEE ; Yoonseok HEO ; Joong Min PARK ; Yong Jin KIM ; Seong Min KIM ; Do Joong PARK ; Sang Moon HAN ; Kyung Won SHIM ; Yeon Ji LEE ; Ja Youn LEE ; Jin Won KWON
Yonsei Medical Journal 2016;57(4):956-962
PURPOSE: Bariatric surgery is relatively new in Korea, and studies comparing different bariatric procedures in Koreans are lacking. This study aimed to compare the clinical outcomes of laparoscopic adjustable gastric banding (LAGB), Roux-en-Y gastric bypass (RYGB), and sleeve gastrectomy (SG) for treating morbidly obese Korean adults. MATERIALS AND METHODS: In this multicenter retrospective cohort study, we reviewed the medical records of 261 obese patients who underwent different bariatric procedures. Clinical outcomes were measured in terms of weight loss and resolution of comorbidities, such as diabetes, hypertension, and dyslipidemia. Safety profiles for the procedures were also evaluated. RESULTS: In terms of weight loss, the three procedures showed similar results at 18 months (weight loss in 52.1% for SG, 61.0% for LAGB, and 69.2% for RYGB). Remission of diabetes, hypertension, and dyslipidemia was more frequent in patients who underwent RYGB (65.9%, 63.6%, and 100% of patients, respectively). Safety profiles were similar among groups. Early complications occurred in 26 patients (9.9%) and late complications in 32 (12.3%). In the LAGB group, five bands (6.9%) were removed. Among all patients, one death (1/261=0.38%) occurred in the RYGB group due to aspiration pneumonia. CONCLUSION: The three bariatric procedures were comparable in regards to weight-loss outcomes; nevertheless, RYGB showed a higher rate of comorbidity resolution. Bariatric surgery is effective and relatively safe; however, due to complications, some bands had to be removed in the LAGB group and a relatively high rate of reoperations was observed in the RYGB group.
Adult
;
Cohort Studies
;
Comorbidity
;
Female
;
*Gastrectomy/adverse effects
;
*Gastric Bypass/adverse effects
;
Humans
;
Male
;
Obesity, Morbid/epidemiology/*surgery
;
Republic of Korea
;
Retrospective Studies
;
Treatment Outcome
;
Weight Loss
4.Evaluation of General Toxicity and Genotoxicity of the Silkworm Extract Powder.
Hyun Suk HEO ; Jae Hun CHOI ; Jung Ja OH ; Woo Joo LEE ; Seong Sook KIM ; Do Hoon LEE ; Hyun Kul LEE ; Si Whan SONG ; Kap Ho KIM ; Yang Kyu CHOI ; Kang Sun RYU ; Boo Hyon KANG
Toxicological Research 2013;29(4):263-278
The silkworm extract powder contain 1-deoxynojirimycin (DNJ), a potent alpha-glycosidase inhibitor, has therapeutic potency against diabetes mellitus. Therefore, natural products containing DNJ from mulberry leaves and silkworm are consumed as health functional food. The present study was performed to evaluate the safety of the silkworm extract powder, a health food which containing the DNJ. The repeated toxicity studies and gentic toxicity studies of the silkworm extract powder were performed to obtain the data for new functional food approval in MFDS. The safety was evaluated by a single-dose oral toxicity study and a 90 day repeated-dose oral toxicity study in Sprague-Dawley rats. The silkworm extract powder was also evaluated for its mutagenic potential in a battery of genetic toxicity test: in vitro bacterial reverse mutation assay, in vitro chromosomal aberration test, and in vivo mouse bone marrow micronucleus assay. The results of the genetic toxicology assays were negative in all of the assays. The approximate lethal dose in single oral dose toxicity study was considered to be higher than 5000 mg/kg in rats. In the 90 day study, the dose levels were wet at 0, 500, 1000, 2000 mg/kg/day, and 10 animals/sex/dose were treated with oral gavage. The parameters that were monitored were clinical signs, body weights, food and water consumptions, ophthalmic examination, urinalysis, hematology, serum biochemistry, necropsy findings, organ weights, and histopathological examination. No adverse effects were observed after the 90 day administration of the silkworm extract powder. The No-Observed-Adverse-Effect-Level (NOAEL) of silkworm extract powder in the 90 day study was 2000 mg/kg/day in both sexes, and no target organ was identified.
1-Deoxynojirimycin
;
Animals
;
Biochemistry
;
Biological Agents
;
Body Weight
;
Bombyx*
;
Bone Marrow
;
Chromosome Aberrations
;
Diabetes Mellitus
;
Functional Food
;
Food, Organic
;
Hematology
;
Mice
;
Micronucleus Tests
;
Morus
;
Mutagenicity Tests
;
Organ Size
;
Rats
;
Rats, Sprague-Dawley
;
Toxicology
;
Urinalysis
;
Drinking
5.Efficacy and safety of entecavir plus carnitine complex (GODEX(R)) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study.
Dae Won JUN ; Byung Ik KIM ; Yong Kyun CHO ; Hong Ju KIM ; Young Oh KWON ; Soo Young PARK ; Sang Young HAN ; Yang Hyun BAEK ; Yong Jin JUNG ; Hwi Young KIM ; Won KIM ; Jeong HEO ; Hyun Young WOO ; Seong Gyu HWANG ; Kyu Sung RIM ; Jong Young CHOI ; Si Hyun BAE ; Young Sang LEE ; Young Suck LIM ; Jae Youn CHEONG ; Sung Won CHO ; Byung Seok LEE ; Seok Hyun KIM ; Joo Hyun SOHN ; Tae Yeob KIM ; Yong Han PAIK ; Ja Kyung KIM ; Kwan Sik LEE
Clinical and Molecular Hepatology 2013;19(2):165-172
BACKGROUND/AIMS: Carnitine and vitamin complex (Godex(R)) is widely used in patients with chronic liver disease who show elevated liver enzyme in South Korea. The purpose of this study is to identify the efficacy and safety of carnitine from entecavir combination therapy in Alanine aminotransferase (ALT) elevated Chronic Hepatitis B (CHB) patients. METHODS: 130 treatment-naive patients with CHB were enrolled from 13 sites. The patients were randomly selected to the entecavir and the complex of entecavir and carnitine. The primary endpoint of the study is ALT normalization level after 12 months. RESULTS: Among the 130 patients, 119 patients completed the study treatment. The ALT normalization at 3 months was 58.9% for the monotherapy and 95.2% for the combination therapy (P<0.0001). ALT normalization rate at 12 months was 85.7% for the monotherapy and 100% for the combination group (P=0.0019). The rate of less than HBV DNA 300 copies/mL at 12 months was not statistically significant (P=0.5318) 75.9% for the monotherapy, 70.7% for the combination and it was. Quantification of HBsAg level was not different from the monotherapy to combination at 12 months. Changes of ELISPOT value to evaluate the INF-gamma secretion by HBsAg showed the increasing trend of combination therapy compare to mono-treatment. CONCLUSIONS: ALT normalization rate was higher in carnitine complex combination group than entecavir group in CHB. Combination group was faster than entecavir mono-treatment group on ALT normalization rate. HBV DNA normalization rate and the serum HBV-DNA level were not changed by carnitine complex treatment.
Adult
;
Alanine Transaminase/blood
;
Antiviral Agents/*therapeutic use
;
Carnitine/*therapeutic use
;
DNA, Viral/analysis
;
Drug Therapy, Combination
;
Enzyme-Linked Immunospot Assay
;
Female
;
Guanine/*analogs & derivatives/therapeutic use
;
Hepatitis B Surface Antigens/blood
;
Hepatitis B e Antigens/blood
;
Hepatitis B virus/genetics
;
Hepatitis B, Chronic/*drug therapy
;
Humans
;
Interferon-gamma/metabolism
;
Male
;
Middle Aged
;
Mitochondria/physiology
;
Treatment Outcome
;
Vitamin B Complex/*therapeutic use
6.Lessons from the Initial Experience of Laparoscopic Liver Resection.
Ja Yeon KIM ; Young Joon AHN ; Hae Won LEE ; In Mok JUNG ; Jung Kee CHUNG ; Seung Chul HEO ; Ki Tae HWANG ; Hye Seong AHN
Journal of Minimally Invasive Surgery 2012;15(4):93-99
PURPOSE: This study was conducted to evaluate the initial experience of 24 cases of laparoscopic liver resection by a single surgeon to determine its feasibility and report perioperative complications associated with this technique. METHODS: A retrospective analysis of data from 24 patients who received attempted laparoscopic liver resections for primary liver tumors from November 2008 to April 2012 was conducted. Sixteen benign and eight primary malignant lesions were included. The patient's electronic medical records including age, gender, underlying disease, past medical history, type of operations, operative time, complications, conversion rates, and length of hospital stay were reviewed. RESULTS: The mean age of the patients was 52.6 years and the mean operation time was 263.7 minutes. The overall morbidity was 12.5% and the mortality was zero. One case was converted to open surgery (4.2%), while intraoperative transfusion was conducted in four cases. The types of operations included left hepatectomy (n=12, 50%; 3 with CBD exploration), left lateral sectionecectomy (n=4, 16.7%; 1 with cholecystectomy), partial hepatectomy for benign tumor (n=3, 12.5%: 1 with cholecystectomy), right hepatectomy (n=1, 4.1%), S6 segmentectomy (n=1, 4.1%), and tumorectomy (n=3, 12.5%). The mean estimated blood loss during operation was 375.3 cc and the postoperative hospital stay was 7.7 days. Additionally, one intraoperative complication and two postoperative complications occurred (12.5%). There was no postoperative mortality. CONCLUSION: The results of this study indicate that laparoscopic surgery with HBP training is suitable for laparoscopic liver resection. However, to ensure safety of the liver resection and the advantages of laparoscopic surgery, a thorough understanding of hepatic anatomy and elaborate surgical planning is essential.
Dietary Sucrose
;
Electronic Health Records
;
Hepatectomy
;
Humans
;
Intraoperative Complications
;
Laparoscopy
;
Length of Stay
;
Liver
;
Mastectomy, Segmental
;
Operative Time
;
Postoperative Complications
;
Retrospective Studies
7.Bariatric surgery versus conventional therapy in obese Korea patients: a multicenter retrospective cohort study.
Yoon Seok HEO ; Joong Min PARK ; Yong Jin KIM ; Seong Min KIM ; Do Joong PARK ; Sang Kuon LEE ; Sang Moon HAN ; Kyung Won SHIM ; Yeon Ji LEE ; Ja Youn LEE ; Jin Won KWON
Journal of the Korean Surgical Society 2012;83(6):335-342
PURPOSE: In Korea, the results of bariatric surgery have not been compared with those of nonsurgical treatment. The purpose of this study was to evaluate the effectiveness and safety of bariatric surgery vs. conventional nonsurgical treatment in severely obese Koreans. METHODS: In this retrospective cohort study, we reviewed the medical charts of 261 consecutive subjects who underwent bariatric surgery and 224 subjects who were treated with weight control medication and lifestyle modification therapy between January 2008 and February 2011. Measures of clinical effectiveness, including change in weight (%) and comorbid diseases, and occurrence of complications, were investigated for 18 months after bariatric surgery. RESULTS: Body mass index (BMI) was higher in the surgery group than in the conventionally treated group (mean +/- standard deviation, 39.0 +/- 6.2 vs. 34.3 +/- 3.8). Diabetes was more prevalent in the surgery group than in the conventionally treated group (39.1% vs. 12.9%). The change in weight (%) between baseline and 18 months posttreatment was significantly greater in the surgery group (22.6%) than in the conventional therapy group (6.7%). While 57%, 47%, and 84% of subjects recovered from diabetes, hypertension, and dyslipidemia, respectively, in the surgery group, 10%, 20%, and 24% of subjects recovered from these conditions in the conventional group. Fifty-one subjects (19.5%) in the surgery group reported 61 complications (23.4%). CONCLUSION: Bariatric surgery in Korea was significantly more effective than conventional treatment for weight loss and recovery from comorbidities such as diabetes, hypertension, and dyslipidemia, with a reasonable complication rate.
Bariatric Surgery
;
Body Mass Index
;
Cohort Studies
;
Comorbidity
;
Dyslipidemias
;
Hypertension
;
Korea
;
Life Style
;
Obesity, Morbid
;
Retrospective Studies
;
Weight Loss
8.Adenosquamous Carcinoma Arising in Congenital Choledochal Cyst.
Jae Yool JANG ; Young Joon AHN ; Jung Kee CHUNG ; In Mok JUNG ; Seung Chul HEO ; Ki Tae HWANG ; Hye Seong AHN ; Eun SHIN ; Ja Hee SEO
Journal of the Korean Surgical Society 2010;78(5):325-329
Adenosquamous carcinoma arising in congenital choledochal cyst is very rare and herein we report a case thereof. A 37-year-old woman was referred for further evaluation of pancreas head mass and a hepatic nodule on CT. She had been diagnosed with congenital choledochal cyst at 22-years-old and received Roux-en-Y choledochojejunostomy at that time. Endoscopic ultrasonography-guided biopsy proved the pancreas head mass as a squamous cell carcinoma and liver biopsy also proved the liver mass as a metastatic squamous cell carcinoma. We performed pancreaticoduodenectomy and tumorectomy of metastatic liver nodule. Grossly, the primary lesion was located at intrapancreatic portion of choledochal cyst. Histologically, the primary lesion and hepatic nodule was metastatic adenosquamous carcinoma. So far, there have been only three cases of adenosquamous carcinoma arising in congenital choledochal cyst reported in English-language literature. This is another case and the first case reported in Korea.
Adult
;
Biopsy
;
Carcinoma, Adenosquamous
;
Carcinoma, Squamous Cell
;
Choledochal Cyst
;
Choledochostomy
;
Female
;
Head
;
Humans
;
Korea
;
Liver
;
Pancreas
;
Pancreaticoduodenectomy
9.Fitness of Diet-Related Factors Explaining the Self-Rated Health (SRH) in Rural Older Adults with Discriminant Analysis.
Myeong Hwa CHA ; Seong Ja HEO ; Hyun Sook YOUN
Korean Journal of Community Nutrition 2008;13(5):723-732
The purpose of this study was to identify the influence of diet related factors, such as diet behaviors, food intake, and nutrient intakes, on self-rated health (SRH). Also, in order to determine fitness of classification for SRH reflecting diet related factors, this study surveyed older adults in Gyeongnam province. A total of 101 responses were collected using the interview survey method. The self- rated health of rural older adults was poor as reported by 49.5%. The level of self-rated health was found to be related to the frequencies of coffee and snack, use of sugar and vegetable in diet, the amount of total food intake, and cholesterol intake. The result of discriminant analysis, which was conducted to assess the adequacy of SRH classification and to determine the class of observation, showed frequency of coffee and use of vegetable in diet among 47 variables as predictive variables for explaining SRH. The fitness of self-rated health function was high to 47.7%. Therefore, diet-related factors were ascertained to be important variables to predict SRH.
Adult
;
Cholesterol
;
Coffee
;
Surveys and Questionnaires
;
Diet
;
Discriminant Analysis
;
Eating
;
Humans
;
Snacks
;
Vegetables
10.Acute Lymphadenitis with Cellulitis Caused by Staphylococcus lugdunensis.
Jae Hyen KIM ; Ja Young LEE ; Hye Ran KIM ; Kyung Wook HEO ; Seong Kook PARK ; Jeong Nyeo LEE ; Seong Mi YU ; Jeong Hwan SHIN
The Korean Journal of Laboratory Medicine 2008;28(3):196-200
Although coagulase-negative staphylococci (CNS) have been considered part of the resident flora on the human skin, Staphylococcus lugdunensis is an unusually virulent CNS and can cause many types of infection. We report a rare case of acute lymphadenitis with cellulitis in the right infraauricular region caused by S. lugdunensis. A 62-yr-old woman visited the Department of Otolaryngology of Busan Paik university hospital. She had a palpable mass and swelling in the right infraauricular region and complained of aggressive pain and a febrile sensation in the region for 5 days. On the suspicion of abscess with infection, percutaneous aspiration was performed and smooth, flat, white, opaque colonies grew on a blood agar plate as a pure culture. The biochemical test results showed the organism to be catalase positive, tube coagulase negative, ornithine decarboxylase positive, slide coagulase positive, and latex agglutination tests for coagulase positive. The API Staph Kit was used to identify the isolate to the species level as S. lugdunensis with a 64.6% probability (profile 6716152). We confirmed the species identification of this strain by 16S rDNA sequence analysis. The patient's clinical condition improved with appropriate antimicrobial therapy and pus drainage.
Acute Disease
;
Cellulitis/*diagnosis/*microbiology
;
Drainage
;
Ear, External
;
Female
;
Humans
;
Lymphadenitis/*diagnosis/drug therapy/*microbiology
;
Microbial Sensitivity Tests
;
Middle Aged
;
RNA, Ribosomal, 16S/genetics
;
Sequence Analysis, DNA
;
Staphylococcal Infections/*diagnosis/microbiology

Result Analysis
Print
Save
E-mail